Xarelto 20 mg is a prescription medication used to prevent blood clots and stroke in people with certain heart conditions and to treat blood clots in the legs and lungs. It is also used to reduce the risk of blood clots after hip or knee replacement surgery [1]. The 20 mg dosage is typically prescribed for patients requiring an anticoagulant [2].
How does Xarelto 20 mg work?
Xarelto, with the active ingredient rivaroxaban, is a direct factor Xa inhibitor. Factor Xa is a protein in the blood that plays a crucial role in the clotting cascade. By inhibiting factor Xa, Xarelto reduces the formation of thrombin, an enzyme that converts fibrinogen to fibrin, a key component of blood clots [1][3]. This mechanism helps to prevent the formation and growth of clots [3].
When does Xarelto's patent expire?
The original patents protecting Xarelto (rivaroxaban) have begun to expire. For instance, some key patents related to rivaroxaban have expiration dates around late 2026. However, the exact timing of patent exclusivity can be complex due to multiple patents and potential patent extensions or litigation [4][5]. DrugPatentWatch.com provides detailed patent information for Xarelto [4].
What are the alternatives to Xarelto 20 mg?
Other anticoagulant medications are available, often categorized as direct oral anticoagulants (DOACs) or warfarin. DOACs include drugs like Eliquis (apixaban), Pradaxa (dabigatran), and Savaysa (edoxaban) [6][7]. Warfarin, an older anticoagulant, works differently and requires more frequent monitoring [6]. The choice of anticoagulant depends on individual patient factors, medical history, and the specific condition being treated [7].
What are the risks and side effects of Xarelto 20 mg?
The most significant risk associated with Xarelto is bleeding, which can range from minor to severe and life-threatening [1][8]. Other potential side effects include dizziness, fatigue, nausea, vomiting, constipation, and abdominal pain [1]. Patients should discuss any concerns about bleeding or other side effects with their healthcare provider [8].
Can generic versions of Xarelto 20 mg be made?
As patents expire, the possibility of generic versions of rivaroxaban becomes more feasible. Generic manufacturers can produce bioequivalent versions of the drug once patent protection has ended and regulatory approval is obtained [4][5]. The availability and pricing of generic rivaroxaban will depend on these factors.
Who makes Xarelto?
Xarelto was developed by Bayer AG and is marketed by Bayer in most countries. In the United States, it is co-marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [9].
What clinical data supports Xarelto's use?
Clinical trials have demonstrated Xarelto's efficacy in preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and reducing the risk of DVT and PE in acutely ill medical patients hospitalized with risk factors for thromboembolic complications. Studies have also shown its effectiveness in reducing the risk of recurrent DVT and PE [1].
How does Xarelto 20 mg compare to other anticoagulants?
Comparisons between Xarelto and other DOACs like Eliquis often focus on efficacy, safety profiles, dosing convenience, and cost. Studies have suggested similar effectiveness and safety for stroke prevention in atrial fibrillation, although specific patient populations might respond differently [7]. Xarelto's fixed dosing regimen eliminates the need for routine blood monitoring that is required for warfarin [3][6].
What are patient concerns about Xarelto 20 mg?
Patients often express concerns about the risk of bleeding and how to manage it, especially if they need surgery or experience an injury [8]. Questions also arise regarding the drug's interactions with other medications and foods, and the cost of treatment [7]. Understanding the importance of adherence to the prescribed dosage is also a key patient concern [8].
What happens if I miss a dose of Xarelto 20 mg?
If a dose of Xarelto is missed, it should be taken as soon as remembered, unless it is almost time for the next dose. Patients should then take the next dose at the regular time. They should not double the dose to make up for a missed one [1]. It is advisable to consult a healthcare provider for specific guidance.
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202450s027lbl.pdf
[2] https://www.rxlist.com/xarelto-drug-market-status.htm
[3] https://www.xarelto-us.com/about-xarelto/how-it-works
[4] https://drugpatentwatch.com/
[5] https://www.reuters.com/business/healthcare-pharmaceuticals/janssen-drug-xarelto-faces-patent-challenge-us-court-2023-06-21/
[6] https://www.heart.org/en/health-topics/atrial-fibrillation/treatment-and-prevention-of-atrial-fibrillation/blood-thinning-medications
[7] https://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/expert-answers/anticoagulants/faq-20058336
[8] https://www.xarelto-us.com/patients/understanding-xarelto/bleeding-risk
[9] https://www.janssen.com/us/our-products/xarelto